Archer Daniels To Expand Citrus Portfolio With Ziegler Buyout
Zacks Investment Research | Mar 18, 2019 08:30AM ET
Archer Daniels Midland Company (NYSE:ADM) takes its quest of enhancing the nutrition portfolio, with citrus ingredients and flavors, to the next level as it agrees to buy Europe-based natural citrus flavor ingredients provider — Ziegler Group. Earlier this month, the company successfully acquired Florida Chemical Company LLC (“FCC”) for $165 million. FCC, the Consumer and Industrial Chemistry Technologies segment of Flotek Industries Inc. (NYSE:FTK) , specializes in citrus-based oils and ingredients.
Coming back to the latest acquisition, Ziegler is a leader in producing natural high-quality citrus oils, extracts, concentrates and compounds for flavor, food and beverage industry customers. The company uses proprietary cold concentration technologies for production. Based in Aufsess, in southern Germany, Ziegler has operations across Europe, the United States and Japan.
This merger with Archer Daniels is likely to bring increased opportunities for growth and creating benefits for Ziegler’s customers. Zeigler will be positioned to take advantage of Archer Daniels’ portfolio of ingredients and global reach. Meanwhile, Archer Daniels will gain from Zeigler’s technology and citrus capabilities.
The combination of Zeigler and Florida Chemical will immediately bolster Archer Daniels’ presence in the natural citrus ingredients market. These acquisitions bring a wide range of innovative citrus solutions and systems for the food, beverage and fragrance customers.
Archer Daniels expects to complete the acquisition by the second quarter of 2019. The acquisition remains conditioned upon the receipt of various regulatory approvals.
Given citrus’ fastest-growing and highest-demand flavors for food and beverages, expansion of the global citrus platform forms a key part of Archer Daniels’ growth strategy. The company is focused on creating global citrus portfolio offering a complete product line for customers.
Further, Archer Daniels is focused on strengthening its Nutrition portfolio. The buyout of WILD Flavors reinforced Archer Daniels’ foothold in the nutrition space, expanding the specialty ingredients portfolio — including vanilla, mint and other savory flavors. Moreover, the Neovia buyout in February 2019 expanded its presence in the animal feed industry. Additionally, the company acquired Rodelle and Protexin, and signed a joint development agreement with China-based biotech company, Qingdao Vland Biotech Group Co., Ltd. These acquisitions reflect Archer Daniels’ focus on improving its portfolio in the Nutrition space.
Management expects increased profits for the Nutrition segment during the first quarter of 2019, driven by operational improvements and gains from acquisitions as well as higher margin and sales. Moreover, the segment’s operating profit is projected to be significantly higher from the first quarter of 2018. Archer Daniels is focused on five major platforms — animal nutrition, health & wellness, carbohydrates, human nutrition, and taste — to boost growth in the future.
Get The News You Want
However, the Nutrition segment witnessed a decline in adjusted operating profit in fourth-quarter 2018. Lower Merchandising and Handling results, including important insurance settlements in other income and dismal performance at Animal Nutrition owing to continuous production issues, were deterrents.
A glimpse of Archer Daniels’ price performance in the past year depicts that this Zacks Rank #3 (Hold) stock has gained 0.3% against the industry ’s 7.3% decline.
Want Better-Ranked Stocks in the Consumer Staples Sector? Check These
Currently, Medifast (NYSE:MED) has an impressive long-term earnings growth rate of 20% and a Zacks Rank #1 (Strong Buy). You can see Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.